Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function - Wikidata - awgldk - TriplyDB

Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function

Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function

http://www.wikidata.org/entity/Q37029184

about

Tyrosine modifications in aging Double Superhelix Model of High Density Lipoprotein Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function Rational drug design applied to myeloperoxidase inhibition.Oxidative risk for atherothrombotic cardiovascular disease.Dysfunctional HDL as a diagnostic and therapeutic target Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein The biology of reactive intermediates in systemic lupus erythematosus.Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway Impact of self-association on function of apolipoprotein A-I Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.Tyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex An azido-biotin reagent for use in the isolation of protein adducts of lipid-derived electrophiles by streptavidin catch and photorelease.Myeloperoxidase, modified lipoproteins, and atherogenesis.Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma An abundant dysfunctional apolipoprotein A1 in human atheroma.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.High-density lipoprotein function, dysfunction, and reverse cholesterol transport.High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity.Dysfunctional HDL and atherosclerotic cardiovascular disease.Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified.Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.Myeloperoxidase-mediated protein lysine oxidation generates 2-aminoadipic acid and lysine nitrile in vivo.Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.

P2860

Q26998450-2A11F9C3-3B10-4F77-80CF-384407F3A579 Q27657720-93D55666-037D-4DA9-AC7C-2BC870C374B8 Q27690671-2FF2C164-1746-4B41-84A5-6F4143FCB1D0 Q30372838-D818AADA-CCA5-4DAB-8F3F-F931F830364D Q33554184-4D71FC7B-12B9-4FAB-96E9-0E307DA8A0E4 Q33604003-C4B4C5C0-DD5F-4E35-895F-747B64373E07 Q33675617-4BCAC16C-5DAE-461D-990F-48C8054F8D1E Q33725659-51B5EE43-E7BE-4CD7-8BBE-870BD37A3912 Q33729198-EF30F8BC-64AC-4ECA-AC04-79898C75B2EB Q33802441-B9A963DA-E310-4406-9E2F-74D9A3D31878 Q33825419-B77B871B-8011-4D7A-A1BA-F9F43679476E Q33897950-4118AA9A-0F60-4835-80F3-B67921CD7A1A Q33902023-5A49564F-2C18-42F4-9134-6082C8130202 Q33937174-4C24B69A-209B-432C-9FE2-563B4C7E7F35 Q34021570-9C3EDF91-F06F-43B3-B685-CE8DE4929A4C Q34291776-898B8E85-D08E-44BC-A4B2-E41B7630DFB5 Q35120941-AC65A718-105C-4F10-99E6-59456C194B8E Q35166941-52801245-894C-4576-B36B-9FFDFCB83A38 Q35371440-BE90B137-CB0D-4640-9E68-CF8CD4C74974 Q35783321-FF12523F-7E74-470A-B379-B55CBB7265B2 Q36520295-E0B3E2FC-4598-468C-9917-80711AA19C64 Q36916720-14D1D1D6-141B-434A-A354-6E2F4D87CD2C Q37123887-FC8BC034-3682-4EFC-94BA-D8159DB00972 Q37343052-556999EB-357F-4706-B453-5CC42E511D74 Q37353408-FC7EA1C5-9E19-46F2-9908-E315769BFBE3 Q37431348-D1AB3FE9-C843-46A6-A5A1-886FF1330BA6 Q37441776-4BD35AB8-9A3A-42E4-B9E8-84778DA51167 Q37581580-8DF14606-EDC9-4E2D-925F-6051F8DE10FB Q37671683-CE1C9E65-0A34-4DB6-87B8-7D98FB991D2E Q37986199-9169626A-4495-43DD-9A08-FFE225CA8A32 Q38059859-37885B34-F673-4E92-AAE5-A464C71BCE10 Q38220761-63C5579A-4465-4371-AEBE-3F93F28E476D Q38344922-FB4AADD7-FF25-4EA5-9CBF-B0B40A4B911F Q38577283-791AE4E9-A952-4FF5-83BF-F147DA3A4926 Q39255171-A74E7FF4-6053-471F-86E5-071D9C816FDE Q42740912-6C96C26B-71CF-41EC-BA31-4F84B74665F5 Q47385866-9816FC4C-5EFA-4E2E-8CFF-EDB524866C26 Q49582789-87D32DA0-C511-4A54-AF3B-B6E87208AD16 Q51204343-F2B94E4E-7B13-4C34-B0DA-3ADE5398B115 Q52673953-12DAD442-F179-4036-8341-3F022B5624DF

P2860

Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function

http://www.wikidata.org/entity/Q37029184

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Apolipoprotein A-I tryptophan ...... dase-mediated loss of function

@en

Apolipoprotein A-I tryptophan ...... ase-mediated loss of function.

@nl

type

label

Apolipoprotein A-I tryptophan ...... dase-mediated loss of function

@en

Apolipoprotein A-I tryptophan ...... ase-mediated loss of function.

@nl

prefLabel

Apolipoprotein A-I tryptophan ...... dase-mediated loss of function

@en

Apolipoprotein A-I tryptophan ...... ase-mediated loss of function.

@nl

P1433

Q37029184-E9818168-18E8-4EFA-A751-16107452173E

P1476

Q37029184-F97A70A4-09E0-4615-9AB8-2217B78B8A93

P2093

Q37029184-1F23EAC8-84FB-4269-87F1-8D1FD2EB198A

Q37029184-545AC158-103B-460A-B7A7-BBB36EF09CA8

Q37029184-64D110D6-FFAD-4129-B648-A4A4A31B66BA

Q37029184-7C087D9C-D028-405C-97F4-846AF1992000

Q37029184-9616485B-E3DB-41C5-B89F-6A7AC772198C

Q37029184-FCC9C561-53FD-40F2-BB6D-ABD2187674F8

P2860

Q37029184-076381DB-D38A-4AD9-BE95-C452F62921DF

Q37029184-1623C793-2828-49A8-8BA5-303F0EEC4532

Q37029184-1723A0CA-2E4D-4D41-8E0F-6031A870B65F

Q37029184-3E68E36D-7E07-4E57-89E3-3130CFE4D0CD

Q37029184-5CDC31FF-4363-40CA-AEFB-9229DC697FBB

Q37029184-6088905C-6C5F-4FBB-ADFA-929F2BCCB4A0

Q37029184-6B3EE448-7AE8-4E89-B346-FD82D52F5EC7

Q37029184-876CCB09-3B1E-49E1-B942-77EFDD444CB8

Q37029184-8BA00A04-60A4-479A-BC42-374CB2D3670A

Q37029184-945BCC4C-8FE3-48EF-A0FC-C6CF463BEFA2

P304

Q37029184-C8AFAE84-0D47-4A56-84BE-74634FD953E3

P31

Q37029184-D64121B8-8582-4530-A71D-A89309F3AC08

P356

Q37029184-A2C67149-E7E6-4228-B673-EF6DF31F31F4

P407

Q37029184-2F639262-7815-4137-A025-BAD6CE5FB858

P433

Q37029184-DD011352-E74E-4396-87CD-81FB9833DAB0

P478

Q37029184-7489D07A-ABD7-4752-960F-40CB56F1138E

P50

Q37029184-23F9A1DB-0681-42DD-8E18-085DC16049D7

Q37029184-B62725C6-0B5A-4D8A-A26D-D2A8E3FB4A43

P577

Q37029184-C9F1CFE8-ABDA-418D-AB7C-C632AE7DEE63

P698

Q37029184-85EFAEB4-F4E3-4922-B8A8-A76FA8C2A6DE

P932

Q37029184-28387649-818F-497C-96CA-496B553AC42E

P356

ATVBAHA.108.173815

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Apolipoprotein A-I tryptophan ...... dase-mediated loss of function

@en

P2093

Dao-Quan Peng

http://www.w3.org/2001/XMLSchema#string

Gregory Brubaker

http://www.w3.org/2001/XMLSchema#string

Jonathan D Smith

http://www.w3.org/2001/XMLSchema#string

Lemin Zheng

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

Zhiping Wu

http://www.w3.org/2001/XMLSchema#string

P2860

ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Studies on the chlorinating activity of myeloperoxidase

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

Experimentally determined hydrophobicity scale for proteins at membrane interfaces

Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein.

Structural models of human apolipoprotein A-I: a critical analysis and review.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

P304

2063-2070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.108.173815

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Belinda Willard

P577

2008-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18688016

http://www.w3.org/2001/XMLSchema#string

P932

2610262

http://www.w3.org/2001/XMLSchema#string